MINNEAPOLIS, Dec. 29, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Thursday, January 21st at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Thursday, January 21st.
This call is being webcast by NASDAQ OMX and can be accessed at Vascular Solutions web site at www.vasc.com. Go to the investor relations portion of the company's website, on the day of the conference call, and click on conference call icon.
For further information about Vascular Solutions, connect to http://www.vasc.com.
CONTACT: Media Contact
Jory Bartels, Legal Project Coordinator
(763) 656-4300


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 



